SCHEMBL12428331

SCHEMBL12428331

Cc1ccc(N2CCCCc3cc(/C=C/C=C4\C(=O)N(c5ccccc5)N=C4C(=O)O)ccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 12/20 0.47
MAPT P10636 10/20 0.47
MEN1 O00255 9/20 0.47
ALDH1A1 P00352 7/20 0.47
MAPK1 P28482 6/20 0.47
L3MBTL1 Q9Y468 6/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TDP1 Q9NUW8 4/20 0.44
HTT P42858 4/20 0.44
POLB P06746 4/20 0.44
LMNA P02545 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MDM2 Q00987 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
PKM P14618 2/20 0.42
OPRK1 P41145 2/20 0.42
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
SRD5A1 P18405 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428197 0.97 KMT2A (0.48) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428236 0.95 MAPT (0.46) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428334 0.93 MAPT (0.40) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428220 0.92 KMT2A (0.47) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL14289165 0.92 MAPT (0.42) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428354 0.91 MAPT (0.41) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428355 0.90 KMT2A (0.42) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428256 0.90 MAPT (0.52) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428234 0.90 MAPT (0.42) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL12428352 0.89 MAPT (0.39) KMT2AMAPTMEN1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
EP-1885015-A1 DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE Nippon Kayaku Kabushiki Kaisha (JP) 2008-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 KMT2A 105/4885MAPT 4642/4885MEN1 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.